BoardBase

Ticker

HIK

FTSE Rank

114

18

People

7

Board Members

11

Executives

Country: United Kingdom (UK)
Industry: Pharmaceuticals
Website: www.hikma.com

Board

	Name	Long Function	Age	Appointed	Tenure	Mkt cap change
▸	Ali Al-Husry	Non-Executive Director	N/A	14 Oct 2005	20y 6m
▸	Cynthia Flowers	Independent Non-Executive Director	N/A	1 Jun 2019	6y 11m
▸	Douglas Hurt	Independent Non-Executive Director	N/A	1 May 2020	6y
▸	Laura Balan	Director	N/A	1 Oct 2022	3y 7m
▸	Deneen Vojta	Director	N/A	1 Nov 2022	3y 6m
▸	Victoria Hull	Chairman of the Board	63	1 Nov 2022	3y 6m
	Nina Henderson	Independent Non-Executive Director	N/A	N/A	N/A	—

Board Timeline

	20052010201520202025now
Ali Al-Husry	Non-Executive Director
Cynthia Flowers	Independent Non-Executive Director
Douglas Hurt	Independent Non-Executive Director
Laura Balan	Director
Deneen Vojta	Director
Victoria Hull	Chairman of the Board
Nina Henderson

Committee Chairs

Name	Committee	Board Role	Appointed	Tenure
Douglas Hurt	Audit Committee	Independent Non-Executive Director	1 May 2020	6y
Nina Henderson	Remuneration Committee	Independent Non-Executive Director	N/A	N/A

Executives

Name	Level	Long Function
Said Darwazah	CEO	Chief Executive Officer
Hussein Arkhagha	N-1	Chief People Officer
Mazen Darwazah	N-1	Executive Vice Chairman and President of MENA
Hafrun Fridriksdottir	N-1	President of Generics
Julie Hill	N-1	Senior Vice President, Corporate Quality Compliance and Health & Safety
Bassam Kanaan	N-1	Executive Vice President, Corporate Development and M&A
Areb Kurdi	N-1	Acting Chief Financial Officer
William Larkins	N-1	Executive Vice President and Chief Scientific Officer and President, Sterile Injectables
Helen Middlemist	N-1	Company Secretary
Khalid Nabilsi	N-1	Deputy Chief Executive Officer, North America and Europe
Susan Ringdal	N-1	Executive Vice President, Strategic Planning and Global Affairs